Woman Hospitalized After Using Unlicensed Weight-Loss Injection Sold as Retatrutide
Kay Roscoe, 38, from Birkenhead, experienced severe health issues after using a substance marketed as retatrutide, an experimental weight-loss drug. The UK's medicines regulator, the MHRA, is actively working to stop the illegal distribution of such products.
According to a report from BBC UK, a woman named Kay Roscoe, who is 38 and resides in Birkenhead, described an incident where she became unable to speak or stand before being transported to the hospital subsequent to taking an unlicensed weight-loss injection. Roscoe stated that she had been using a substance advertised as retatrutide, or "reta," for a period of two months before her serious illness.
The experimental drug is not approved for general use and is only accessible through clinical trials. While products claiming to contain retatrutide are widely available online, it is currently unknown whether Kay Roscoe consumed genuine retatrutide.
Roscoe expressed her gratitude to others, stating, "I am the luckiest person to be alive. Honestly I can't say it enough, get off the pens." She recounted that doctors informed her she could have died if her friend had located her just half an hour later.
Roscoe began injecting herself with the substance approximately two months prior to the incident. She mentioned that she was initially drawn to the possibility of achieving faster weight loss after observing posts on social media.
She purchased the injection from a friend and believed it was authentic after scanning a QR code on the pen, which directed her to what appeared to be a pharmaceutical website. Initially, she was satisfied with the weight loss, noting a "drastic amount" within weeks, though the injections also caused a significant reduction in her appetite.
In the days leading up to her hospital admission, Roscoe reported eating very little.
Retatrutide is being developed by Eli Lilly as a potential treatment for obesity. This drug is noted for acting on three hormone receptors, earning it the nickname "triple G," unlike existing weight-loss medications such as Wegovy and Mounjaro which target one or two receptors. Eli Lilly has indicated that it plans to seek approval in the US early next year, and the drug is still undergoing clinical trials.
Eli Lilly has stated that retatrutide has not been approved by any regulator and cannot be legally sold for human use. A spokesperson for the company noted that counterfeit and black market medicines are unverified, unregulated, and potentially dangerous, in some instances, deadly. The company is collaborating with the UK's medicines regulator, the MHRA, law enforcement, and social media platforms to remove illegal items, with the spokesperson adding that sustained, stronger, coordinated law enforcement is necessary to safeguard UK patients from unsafe fake medicines.
Dr Nas Khattak, a research doctor in Chester who has experience with clinical trials for weight-loss drugs, issued a warning regarding the hazards associated with injections sourced from unregulated channels. He stated that one cannot verify the purity, sterility, dose, or even the contents of such substances, and that there is no proper medical oversight if something goes wrong.
Dr Khattak mentioned encountering substances advertised through private sellers, bodybuilding forums, and messaging applications, where users openly shared dosing advice and supplier recommendations. He also referenced serious complications during his NHS hospital work, including a young woman who required intensive care after using a weight-loss injection obtained from a beautician, though the exact substance she took was never determined.
Dr Khattak advised that common side effects of weight-loss injections can include mild nausea, feeling full sooner, constipation, and tiredness. He cautioned that headaches, dizziness, dry mouth, and very dark urine could indicate dehydration and warrant medical consultation. However, he stressed that urgent medical attention should be sought for more severe symptoms, such as persistent vomiting or diarrhea, severe abdominal pain, pain beneath the right ribs, yellowing of the eyes, or significant mood changes.
Following the sharing of her story on Facebook, Roscoe reported receiving messages from around 100 individuals who shared their own experiences with weight-loss injections. She commented that despite the desire to lose weight, she believes the practice is very dangerous. Roscoe also shared the effect her ordeal had on her family, stating they became upset with her and cautioned her against taking the substance. She now intends to resume exercising at the gym and adopt healthier eating habits, urging others not to use needles to achieve a slim physique, citing the risk of not waking up and the potential for family loss over an unknown substance.